State of New Jersey Common Pension Fund D - APELLIS PHARMACEUTICALS INC ownership

APELLIS PHARMACEUTICALS INC's ticker is APLS and the CUSIP is 03753U106. A total of 185 filers reported holding APELLIS PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 0.84 and the average weighting 0.3%.

Quarter-by-quarter ownership
State of New Jersey Common Pension Fund D ownership history of APELLIS PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2024$1,735,445
-30.4%
45,241
+6.6%
0.01%0.0%
Q1 2024$2,493,506
-21.5%
42,421
-20.1%
0.01%
-27.3%
Q4 2023$3,176,411
+35.7%
53,064
-13.7%
0.01%
+37.5%
Q3 2023$2,340,259
-49.8%
61,521
+20.2%
0.01%
-50.0%
Q2 2023$4,663,682
+28.3%
51,193
-7.1%
0.02%
+23.1%
Q1 2023$3,634,066
+21.4%
55,095
-4.8%
0.01%
+18.2%
Q4 2022$2,994,164
-20.0%
57,903
+5.6%
0.01%
-26.7%
Q3 2022$3,745,000
+62.9%
54,834
+7.8%
0.02%
+66.7%
Q2 2022$2,299,000
-23.6%
50,843
-14.2%
0.01%
-10.0%
Q1 2022$3,009,000
-0.5%
59,226
-7.4%
0.01%
+11.1%
Q4 2021$3,023,000
+109.9%
63,934
+46.4%
0.01%
+125.0%
Q3 2021$1,440,000
-53.0%
43,684
-9.8%
0.00%
-60.0%
Q2 2021$3,062,000
+41.7%
48,457
-3.8%
0.01%
+25.0%
Q1 2021$2,161,000
-40.4%
50,359
-20.5%
0.01%
-38.5%
Q4 2020$3,624,000
+44.3%
63,352
-23.9%
0.01%
+30.0%
Q3 2020$2,511,000
+26.9%
83,240
+37.4%
0.01%
+25.0%
Q2 2020$1,978,000
-5.0%
60,570
-22.0%
0.01%
-20.0%
Q1 2020$2,082,000
-12.5%
77,7030.0%0.01%
+11.1%
Q4 2019$2,379,000
+17.4%
77,703
-7.6%
0.01%
+12.5%
Q3 2019$2,026,00084,1000.01%
Other shareholders
APELLIS PHARMACEUTICALS INC shareholders Q3 2021
NameSharesValueWeighting ↓
Octagon Capital Advisors LP 2,503,059$170,959,00029.50%
ACUTA CAPITAL PARTNERS, LLC 554,000$37,838,00016.29%
Avoro Capital Advisors LLC 10,125,000$691,538,00012.78%
Sio Capital Management, LLC 507,700$34,676,00011.02%
Logos Global Management LP 1,300,000$88,790,00010.92%
EcoR1 Capital, LLC 5,183,431$354,028,00010.45%
Cormorant Asset Management, LP 1,478,000$100,947,0007.06%
Finepoint Capital LP 266,090$18,174,0005.98%
Ghost Tree Capital, LLC 275,000$18,783,0005.27%
Boxer Capital, LLC 1,303,700$89,043,0005.01%
View complete list of APELLIS PHARMACEUTICALS INC shareholders